Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-029588
Filing Date
2017-08-01
Accepted
2017-08-01 16:12:34
Documents
50
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 502363
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 234648
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 344532
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 13439
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 13722
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 6383
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 6556
  Complete submission text file 0001140361-17-029588.txt   3771406

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT edge-20170630.xml EX-101.INS 460204
9 XBRL TAXONOMY EXTENSION SCHEMA edge-20170630.xsd EX-101.SCH 32195
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edge-20170630_cal.xml EX-101.CAL 35195
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edge-20170630_def.xml EX-101.DEF 144269
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE edge-20170630_lab.xml EX-101.LAB 527900
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edge-20170630_pre.xml EX-101.PRE 260232
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 17996856
SIC: 2834 Pharmaceutical Preparations